Clinical Trials · NCT04862923

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice

Name: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ASemaglutide

Phase: N/A
Recruitment status: Completed
Sponsor: Novo Nordisk A/S
Enrollment: 336
Start date: May 2021
Locations: 1 site, United Kingdom
Primary endpoint: Change in glycated haemoglobin (HbA1c)

View Semaglutide compound reference